1. |
Raju TN, Nelson KB, Ferriero D, et al. Ischemic perinatal stroke:summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke[J]. Pediatrics, 2007, 120(3):609-616.
|
2. |
Lynch JK. Epidemiology and classification of perinatal stroke[J]. Semin Fetal Neonatal Med, 2009, 14(5):245-249.
|
3. |
Lee J, Croen LA, Backstrand KH, et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant[J]. JAMA, 2005, 293(6):723-729.
|
4. |
曹云. 新生儿惊厥[J]. 中国小儿急救医学, 2009, 16(3):306-308.
|
5. |
Cheong JL, Cowan FM. Neonatal arterial ischaemic stroke:obstetric issues[J]. Semin Fetal Neonatal Med, 2009, 14(5):267-271.
|
6. |
Renaud C, Bonneau C, Presles E, et al. Lipoprotein (a), birth weight and neonatal stroke[J]. Neonatology, 2010, 98(3):225-228.
|
7. |
Krause M, Sonntag B, Klamroth R, et al. Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage:results of a multicentre case-control study[J]. Thromb Haemost, 2005, 93(5):867-871.
|
8. |
李丽华, 张莉, 母得志. 新生儿脑卒中与产前因素[J]. 实用儿科临床杂志, 2006, 21(14):949-950.
|
9. |
Nelson KB, Lynch JK. Stroke in newborn infants[J]. Lancet Neurol, 2004, 3(3):150-158.
|
10. |
李丽华, 张莉, 屈艺, 等. 新生儿脑卒中与产时及产后发病因素[J]. 中国儿童保健杂志, 2007, 15(1):65-66.
|
11. |
母得志. 围生期缺血性脑卒中临床研究面临的问题[J]. 中华妇幼临床医学杂志:电子版, 2013, 9(1):1-4.
|
12. |
Redline, Raymond W. Correlation of placental pathology with perinatal brain injury[J]. Surg Pathol, 2013, 6(1):153-180.
|
13. |
黄春玲, 周丛乐, 汤泽中, 等. 新生儿脑梗死的危险因素[J]. 中华围产医学杂志, 2012, 15(6):337-344.
|
14. |
黄春玲, 周丛乐, 汤泽中. 新生儿脑梗死病因研究进展[J]. 中华围产医学杂志, 2011, 14(1):55-60.
|
15. |
Gawish GE. Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in saudi newborns with stroke[J]. Biochem Genet, 2011, 49(9/10):601-610.
|
16. |
Mallick AA, O'callaghan FJ. The epidemiology of childhood stroke[J]. Eur J Paediatr Neurol, 2010, 14(3):197-205.
|
17. |
Du LN, Bayir H, Lai YC, et al. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway[J]. J Biol Chem, 2004, 279(37):38563-38570.
|
18. |
Maingay-De GF, Lequin MH, Roofthooft DW, et al. Extensive cerebral infarctio in the newborn due to incontinentia pigmenti[J]. Eur J Paediatr Neurol, 2008, 12(4):284-289.
|
19. |
李志华, 陈超. 新生儿脑梗死58例分析[J]. 中华儿科杂志, 2013, 51(1):16-20.
|
20. |
母得志. 新生儿脑卒中的诊断和治疗[J]. 临床儿科杂志, 2010, 28(3):207-211.
|
21. |
Badve CA, Khanna PC, Ishak GE. Neonatal ischemic brain injury:what every radiologist needs to know[J]. Pediatr Radiol, 2012, 42(5):606-619.
|
22. |
Kuker W, Mohrle S, Mader I, et al. MRI for the management of neonatal cerebral infarctions:importance of timing[J]. Childs NervSyst, 2004, 20(10):742-748.
|
23. |
富建华, 毛健, 薛辛东, 等. 磁共振弥散加权成像在新生儿脑梗死早期诊断中的意义及其变化规律[J]. 中华儿科杂志, 2007, 45(5):360-364.
|
24. |
Jordan LC, Rafay MF, Smith SE, et al. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis:results of the international pediatric stroke study[J]. J Pediatrics, 2010, 156(5):U43-U704.
|
25. |
Lebas A, Chabrier S, Fluss J, et al. EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates[J]. Eur J Paediatr Neurol, 2012, 16(3):219-228.
|
26. |
Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children:a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young[J]. Stroke, 2008, 39(9):2644-2691.
|
27. |
Amlie-Lefond C, Deveber G, Chan AK, et al. Use of alteplase in childhood arterial ischaemic stroke:a multicentre, observational, cohort study[J]. Lancet Neurol, 2009, 8(6):530-536.
|
28. |
Wasay M, Dai AI, Ansari M, et al. Cerebral venous sinus thrombosis in children:a multicenter cohort from the United States[J]. J Child Neurol, 2008, 23(1):26-31.
|
29. |
Jenkins DD, Lee T, Chiuzan C, et al. Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy[J]. Pediatr Crit Care Med, 2013, 14(8):786-795.
|
30. |
Klehmet J, Harms H, Richter M, et al. Stroke-induced immunodepression and post-stroke infections:lessons from the preventive antibacterial therapy in stroke trial[J]. Neuroscience, 2009, 158(3):1184-1193.
|
31. |
Velthoven CT, Sheldon RA, Kavelaars A, et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke[J]. Stroke, 2013, 44(5):1426-1432.
|
32. |
廖文斌. 人脐带间充质干细胞移植治疗脑血管疾病的实验研究[D]. 北京:中国协和医科大学, 2009.
|
33. |
Doycheva D, Shih G, Chen H, et al. Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a olitary treatment[J]. Transl Stroke Res, 2013, 4(2):171-178.
|
34. |
Solaroglu I, Tsubokawa T, Cahill J, et al. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat[J]. Neuroscience, 2006, 143(4):965-974.
|
35. |
Kaneko Y, Tajiri N, Su TP, et al. Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro:role of the opioid system[J]. PLoS One, 2012, 7(10):e47583.
|
36. |
Tsai SY, Lee CT, Hayashi T, et al. Delta opioid peptide DADLE and naltrexone cause cell cycle arrest and differentiation in a CNS neural progenitor cell line[J]. Synapse, 2010, 64(4):267-273.
|